Reference priceEUR €170.16Original source price: INR 15,468.75. Converted estimates are available by currency selection.
| Brand | Cipla Ltd. |
|---|---|
| Manufacturer | Cipla Ltd. |
| Prescription required | Yes |
Denoci-OP 60mg Injection
Denosumab (60mg)
Description
Denoci-OP Injection consists of the active ingredient Denosumab. It is a medication used to treat osteoporosis, characterized by weakened bones. It is also prescribed to prevent bone complications in patients with certain types of cancer, such as multiple myeloma and bone metastases. Denoci OP 60mg injection works by inhibiting a protein called RANK ligand, which plays a role in the breakdown of bone tissue. Studies proved it can significantly increase bone density, reducing fracture risk in postmenopausal women with osteoporosis and patients with cancer-related bone loss. Close monitoring of renal function may be necessary for patients with moderate renal impairment.Benefits
Denoci OP injection is used in the treatment of the following conditions: 1.Osteoporosis 2.Bone loss due to hormonal therapy in breast or prostate cancer 3.Multiple myeloma (cancer affects plasma cells in the bone marrow) 4.Bone metastases (cancer that spreads to bone)How to Use
Your doctor or nurse will give you this medicine. Kindly do not self administer.Specification
Your doctor or nurse will give you this medicine. Kindly do not self administer.Side Effects
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them Common side effects of Denoci-OP Rash Musculoskeletal (bone, muscle or joint) pain Eczema Nerve pain Upper respiratory tract infection Sciatica Pain in extremities Headache Back pain Joint pain Urinary tract infection Constipation Abdominal discomfort Hair loss Hypercholesterolemia (high cholesterol) CystitisThis information is for reference only. Consult a qualified healthcare professional before using any medicine.